| dbo:abstract
|
- Genspect is an international non-profit organisation and group founded in June 2021 by psychotherapist Stella O'Malley that describes itself as "gender-critical". The organisation consists of parents, educators, counsellors, and clinicians. Genspect is known for criticizing and opposing gender-affirming care and social and medical transition for transgender people. Genspect opposes allowing transgender people under 25 years old to transition, opposes laws that would ban conversion therapy on the basis of gender identity, and opposes public health coverage for transgender healthcare at any age. Genspect also supports the contentious concept of rapid-onset gender dysphoria (ROGD), which proposes a subclass of gender dysphoria caused by peer influence and social contagion. ROGD has been rejected by major medical organisations due to its lack of evidence and likelihood to cause harm by stigmatizing gender-affirming care. Genspect's positions are contradicted by major medical organizations such as the World Professional Association for Transgender Health (WPATH), the Endocrine Society, the American Psychiatric Association, American Psychological Association, and the American Academy of Pediatrics, which states "robust evidence demonstrates that access to gender-affirming care decreases risk of suicidal ideations, improves mental health, and improves the overall health and well-being of transgender and gender-diverse youth". Genspect is closely affiliated with the Society for Evidence-Based Gender Medicine (SEGM): seven advisors for SEGM are on Genspect's team or advisors, including founder O'Malley. (en)
|
